Essential sequence of influenza B virus hemagglutinin DNA to provide protection against lethal homologous viral infection

DNA and Cell Biology

Volumn 27, Issue 7, 2008, Pages 377-385

  Wang, Fuyan ^a,b   Yang, Wen ^a,b   Fang, Fang ^b   Chang, Haiyan ^b   Yu, Ping ^a   Chen, Ze ^b,c,d  

^a Central South University   (China)

^b HUNAN NORMAL UNIVERSITY   (China)

^c WUHAN INSTITUTE OF VIROLOGY   (China)

^d Shanghai Institute of Biological Products   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; INFLUENZA VACCINE; SIGNAL PEPTIDE; VIRUS ANTIBODY; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE CONSTRUCT; GENE DELETION; GENETIC CODE; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS B; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECOMBINANT PLASMID; SURVIVAL; TREATMENT OUTCOME; VIRUS GENE; VIRUS TITRATION; WEIGHT CHANGE;

ANIMALS; ANTIBODY FORMATION; BASE SEQUENCE; CELLS, CULTURED; DNA, VIRAL; DOGS; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNIZATION; INFLUENZA B VIRUS; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PLASMIDS; PROTEIN SORTING SIGNALS; SEQUENCE HOMOLOGY, NUCLEIC ACID; VACCINES, DNA;

INFLUENZA B VIRUS; MUS; ORTHOMYXOVIRIDAE;

EID: 47049112688     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2007.0706     Document Type: Article

References (40)

1. Berton, M.T., Naeve, C.W., and Webster, R.G. (1984). Antigenic structure of the influenza B virus hemagglutinin: nucleotide sequence analysis of antigenic variants selected with monoclonal antibodies. J Virol 52, 919-927.
2. Caton, A.J., Brownlee, G.G., Yewdell, J.W., and Gerhard, W. (1982). The antigenic structure of the influenza virus A=PR=8=34 hemagglutinin (H1 subtype). Cell 31, 417-427.
3. Chen, Z. (2004). Influenza DNA vaccine: an update. Chin Med J (Engl) 117, 125-132.
4. Chen, Z., Kadowaki, S., Hagiwara, Y., Yoshikawa, T., Matsuo, K., Kurata, T., and Tamura, S. (2000). Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. Vaccine 18, 3214-3222.
5. Chen, Z., Kadowaki, S., Hagiwara, Y., Yoshikawa, T., Sata, T., Kurata, T., and Tamura, S. (2001). Protection against influenza B virus infection by immunization with DNA vaccines. Vaccine 19, 1446-1455.
6. Chen, Z., Matsuo, K., Asanuma, H., Takahashi, H., Iwasaki, T., Suzuki, Y., Aizawa, C., Kurata, T., and Tamura, S. (1999). Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. Vaccine 17, 653-659.
7. Chen, Z., Sahashi, Y., Matsuo, K., Asanuma, H., Takahashi, H., Iwasaki, T., Suzuki, Y., Aizawa, C., Kurata, T., and Tamura, S. (1998). Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Vaccine 16, 1544-1549.
8. Corey, L., Rubin, R.J., Hattwick, M.A., Noble, G.R., and Cassidy, E. (1976). A nationwide outbreak of Reye's Syndrome. Its epidemiologic relationship of influenza B. Am J Med 61, 615-625.
9. Couch, R.B., and Kasel, J.A. (1983). Immunity to influenza in man. Annu Rev Microbiol 37, 529-549.
10. Dushoff, J., Plotkin, J.B., Viboud, C., Earn, D.J., and Simonsen, L. (2006). Mortality due to influenza in the United States - an annualized regression approach using multiple-cause mortality data. Am J Epidemiol 163, 181-187.
11. Ferguson, N.M., Galvani, A.P., and Bush, R.M. (2003). Ecological and immunological determinants of influenza evolution. Nature 422, 428-433.
12. Green, N., Alexander, H., Olson, A., Alexander, S., Shinnick, T.M., Sutcliffe, J.G., and Lerner, R.A. (1982). Immunogenic structure of the influenza virus hemagglutinin. Cell 28, 477-487.
13. Hilleman, M.R. (2002). Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 20, 3068-3087.
14. Hoskins, T.W., Davies, J.R., Smith, A.J., Allchin, A., Miller, C.L., and Pollock, T.M. (1976). Influenza at Christ's Hospital: March, 1974. Lancet 1, 105-108.
15. Jackson, D.C., Russell, R.J., Ward, C.W., and Dopheide, T.A. (1978). Antigenic determinants of influenza virus hemagglutinin. I. Cyanogen bromide peptides derived from A/MEMPHIS/72 hemagglutinin possess antigenic activity. Virology 89, 199-205.
16. Kawamura, K., Kitaura, Y., Morita, H., Deguchi, H., and Kotaka, M. (1985). Viral and idiopathic myocarditis in Japan: a questionnaire survey. Heart Vessels Suppl 1, 18-22.
17. Kim, H.W., Brandt, C.D., Arrobio, J.O., Murphy, B., Chanock, R.M., and Parrott, R.H. (1979). Influenza A and B virus infection in infants and young children during the years 1957-1976. Am J Epidemiol 109, 464-479.
18. Krystal, M., Elliott, R.M., Benz, E.W., Jr., Young, J.F., and Palese, P. (1982). Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes. Proc Natl Acad Sci USA 79, 4800-4804.
19. Krystal, M., Young, J.F., Palese, P., Wilson, I.A., Skehel, J.J., and Wiley, D.C. (1983). Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains. Proc Natl Acad Sci USA 80, 4527-4531.
20. Lamb, R.A., and Krug, R.M. (1996). Orthomyxoviridae: the virus and their replication. In Virology. Fields, B.N., Knipe, D.M., and Howley, P.M., eds. (Lippincott Raven, Philadelphia), pp. 1353-1396.
21. Li, X., Fang, F., Song, Y., Yan, H., Chang, H., Sun, S., and Chen, Z. (2006). Essential sequence of influenza neuraminidase DNA to provide protection against lethal viral infection. DNA Cell Biol 25, 197-205.
22. Lubeck, M.D., and Gerhard, W. (1981). Topological mapping antigenic sites on the influenza A/PR/8/34 virus hemagglutinin using monoclonal antibodies. Virology 113, 64-72.
23. Meyer, H.M., Jr., Hopps, H.E., Parkman, P.D., and Ennis, F.A. (1978). Review of existing vaccines for influenza. Am J Clin Pathol 70, 146-152.
24. Molinari, M., and Helenius, A. (2000). Chaperone selection during glycoprotein translocation into the endoplasmic reticulum. Science 288, 331-333.
25. Niwa, H., Yamamura, K., and Miyazaki, J. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193-199.
26. Nolan, T.F., Jr., Goodman, R.A., Hinman, A.R., Noble, G.R., Kendal, A.P., and Thacker, S.B. (1980). Morbidity and mortality associated with influenza B in the United States, 1979-1980. A report from the Center for Disease Control. J Infect Dis 142, 360-362.
27. Phelan, M.A., Mayner, R.E., Bucher, D.J., and Ennis, F.A. (1980). Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents. J Biol Stand 8, 233-242.
28. Qiu, M., Fang, F., Chen, Y., Wang, H., Chen, Q., Chang, H., Wang, F., Wang, H., Zhang, R., and Chen, Z. (2006). Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase- expressing DNA in BALB/c mice. Biochem Biophys Res Commun 343, 1124-1131.
29. Reed, L.J., and Muench, H. (1938). A simple method of estimating fifty per cent endpoints. Am J Hyg 27, 493-497.
30. Sekikawa, K., and Lai, C.J. (1983). Defects in functional expression of an influenza virus hemagglutinin lacking the signal peptide sequences. Proc Natl Acad Sci USA 80, 3563-3567.
31. Tonegawa, K., Nobusawa, E., Nakajima, K., Kato, T., Kutsuna, T., Kuroda, K., Shibata, T., Harada, Y., Nakamura, A., and Itoh, M. (2003). Analysis of epitope recognition of antibodies induced by DNA immunization against hemagglutinin protein of influenza A virus. Vaccine 21, 3118-3125.
32. Townsend, A.R., Bastin, J., Gould, K., and Brownlee, G.G. (1986). Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence. Nature 324, 575-577.
33. Tung, C.S., Goodman, J.L., Lu, H., and Macken, C.A. (2004). Homology model of the structure of influenza B virus HA1. J Gen Virol 85, 3249-3259.
34. Underwood, P.A. (1982). Mapping of antigenic changes in the haemagglutinin of Hong Kong influenza (H3N2) strains using a large panel of monoclonal antibodies. J Gen Virol 62 (Pt 1), 153-169.
35. Wang, Q., Cheng, F., Lu, M., Tian, X., and Ma, J. (2008). Crystal Structure of Unliganded Influenza B Virus Hemagglutinin. J Virol 82, 3011-3020.
36. Waterfield, M.D., Espelie, K., Elder, K., and Skehel, J.J. (1979). Structure of the haemagglutinin of influenza virus. Br Med Bull 35, 57-63.
37. Weis, W.I., Cusack, S.C., Brown, J.H., Daniels, R.S., Skehel, J.J., and Wiley, D.C. (1990). The structure of a membrane fusion mutant of the influenza virus haemagglutinin. EMBO J 9, 17-24.
38. Wiley, D.C., and Skehel, J.J. (1987). The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 56, 365-394.
39. Wilson, I.A., Skehel, J.J., and Wiley, D.C. (1981). Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289, 366-373.
40. Zhang, F., Chen, J., Fang, F., Zhou, Y., Wu, J., Chang, H., Zhang, R., Wang, F., Li, X., Wang, H., Ma, G., and Chen, Z. (2005). Maternal immunization with both hemagglutinin- and neuraminidase-expressing DNAs provides an enhanced protection against a lethal influenza virus challenge in infant and adult mice. DNA Cell Biol 24, 758-765.